A secondary objective of this head-to-head study of lisdexamfetamine dimesylate ( LDX ) and atomoxetine ( ATX ) was to assess treatment response rates in children and adolescents with attention-deficit hyperactivity disorder ( ADHD ) and an inadequate response to methylphenidate ( MPH ) .